- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/82 - Oxygen atoms with an aryl radical attached in position 4
Patent holdings for IPC class C07D 239/82
Total number of patents in this class: 27
10-year publication summary
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
3
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4495 |
4 |
| Merck Patent GmbH | 5730 |
2 |
| Novartis AG | 10306 |
1 |
| The Regents of the University of California | 20646 |
1 |
| Amgen Inc. | 4414 |
1 |
| JSR Corporation | 2539 |
1 |
| Biocodex | 103 |
1 |
| D.E. Shaw Research, LLC | 97 |
1 |
| Ideaya Biosciences, Inc. | 155 |
1 |
| Indiana University Research and Technology Corporation | 782 |
1 |
| Katholieke Universiteit Leuven | 1270 |
1 |
| Medshine Discovery Inc. | 588 |
1 |
| Shionogi & Co., Ltd. | 869 |
1 |
| Trustees of Boston University | 985 |
1 |
| University of Houston System | 1121 |
1 |
| University of Tennessee Research Foundation | 755 |
1 |
| Vib VZW | 896 |
1 |
| Xiamen University | 569 |
1 |
| Cavion, Inc. | 23 |
1 |
| Relay Therapeutics, Inc. | 83 |
1 |
| Other owners | 3 |